Silk Road Medical, Inc. (SILK): Kapitalisasi marang pendapatan

Simbol lan logo merek Silk Road Medical, Inc. (SILK)

Silk Road Medical, Inc. (SILK) relies on exclusive TCAR technology, which eliminates the risk of embolism during surgeries. This price-to-sales chart confirms asset stability, where the current status is 5.80. Niche leadership in vascular surgery minimizes risks, while the scaling strategy prepares the company for integration into a global medtech behemoth.

SILK Multiplikator P/S Silk Road Medical, Inc. (04.07.2022 - 28.09.2024)

Rincian analitis perusahaan silkroadmed.com (SILK)

Analisis umum perusahaan:SILK Silk Road Medical, Inc.
Barang utama Silk Road Medical, Inc

For Silk Road Medical, Inc. (SILK) and its unique TCAR technology, the price-to-sales ratio determines how much investors are willing to pay for every dollar of sales from its innovative artery cleansing systems. By analyzing the historical P/S, one can separate market noise from the business's fundamental value, assessing whether the defensive qualities of the company's patents are overvalued relative to actual cash flows.

Pesaing Silk Road Medical, Inc

DXCM (DexCom Inc) - Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S PEN (penumbrainc.com)|NOVT - Kapitalisasi marang pendapatan|Haemonetics - Multiplikator P/S|Rega marang dodolan Inspire Medical Systems|PRCT: Multiplikator P/S|Rasio kapitalisasi marang pendapatan CNMD|PLSE (Pulse Medical) - Multiplikator P/S|InMode Corp (INMD) - Koefisien rega marang pendapatan|Multiplikator P/S PMI|Kapitalisasi marang pendapatan Surmodics, Inc. SRDX|Multiplikator P/S SENS (senseonics.com)|Multiplikator P/S NeuroPace Inc NPCE|TCMD - Rasio rega marang pendapatan|SNWV: Rasio rega marang pendapatan|Outset Medical Corp (OM) - Rasio rega marang pendapatan|SmartVest - Rasio kapitalisasi pasar marang pendapatan|LNSR (LENSAR Inc) - Multiplikator P/S|Rega marang dodolan AVITA Medical Inc. RCEL|Rasio rega marang pendapatan Profound Medical (PROF)|Baird Medical Corp (BDMD) - Multiplikator rega marang pendapatan|EDAP TMS SA - Kapitalisasi marang pendapatan|Multiplikator P/S Bovie Medical APYX|IceCure Medical Ltd. - Multiplikator P/S|Koefisien rega marang pendapatan Pulmonx LUNG|TELA Bio (TELA) - Rasio rega marang pendapatan|Rasio rega marang dodolan CTSO (CytoSorbents Corp.)|Rasio rega marang pendapatan sensushealthcare.com|Kapitalisasi marang pendapatan Zynex, Inc. (ZYXI)|Multiplikator P/S ECOR|RBOT - Rega marang dodolan|Rasio rega marang pendapatan inspira-technologies.com IINN|Kapitalisasi marang volume dodolan ICU (SeaStar Medical Holding Corp.)|IRIX: Kapitalisasi marang pendapatan|ibs.inc - Kapitalisasi marang volume dodolan|XAIR: Multiplikator P/S|Rasio rega marang dodolan PFSA (Profusa Inc.)|Kapitalisasi marang pendapatan SSKN|Rasio rega marang pendapatan GCTK|Rasio rega marang pendapatan NanoVibronix (NAOV)|Venus Concept - Rasio kapitalisasi marang pendapatan|Multiplikator P/S NUWE (Nuwellis Corp)|Rasio kapitalisasi pasar marang pendapatan AEMD|ASXC - Rasio rega marang pendapatan|Multiplikator rega marang pendapatan Avinger, Inc (AVGR)|BSGM: Multiplikator P/S|Cutera (CUTR) - Multiplikator P/S|KNW (Know Labs) - Multiplikator P/S|Kapitalisasi marang pendapatan Inari Medical (NARI)|Rasio rega marang pendapatan nevro.com (NVRO)|RSLS (ReShape Lifesciences, Inc.) - Rasio kapitalisasi pasar marang pendapatan